Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia

J Pediatr Hematol Oncol. 2007 Feb;29(2):130. doi: 10.1097/MPH.0b013e318030d289.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antifungal Agents / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Demyelinating Diseases / chemically induced
  • Demyelinating Diseases / physiopathology
  • Electromyography
  • Fever / chemically induced
  • Fever / drug therapy
  • Humans
  • Lung Diseases / drug therapy
  • Lung Diseases / etiology
  • Male
  • Neural Conduction / drug effects
  • Neurotoxicity Syndromes / etiology
  • Neurotoxicity Syndromes / physiopathology*
  • Neutropenia / chemically induced
  • Neutropenia / drug therapy
  • Peripheral Nervous System Diseases / chemically induced
  • Peripheral Nervous System Diseases / physiopathology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Prednisone / therapeutic use
  • Triazoles / adverse effects*
  • Vincristine / adverse effects*

Substances

  • Antifungal Agents
  • Antineoplastic Agents
  • Triazoles
  • Vincristine
  • posaconazole
  • Prednisone